Effect of long-term infection with nef-defective attenuated hiv type 1 on CD4+ and CD8+ T lymphocytes: Increased CD45RO+CD4+ T lymphocytes and limited activation of CD8+ T lymphocytes

AIDS Research and Human Retroviruses

Volumn 15, Issue 17, 1999, Pages 1519-1527

  Zaunders, John J ^a   Geczy, Andrew F ^b   Dyer, Wayne B ^b   McIntyre, Larissa B ^c   Cooley, Margaret A ^d   Ashton, Lesley J ^e   Raynes Greenow, Camille H ^b   Learmont, Jenny ^b   Cooper, David A ^a,e   Sullivan, John S ^b  

^a ST VINCENT S HOSPITAL   (Australia)

^b AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^c New South Wales Government   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN; NEF PROTEIN; PADGEM PROTEIN; VIRUS RNA;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS MUTANT; VIRUS STRAIN;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, SURFACE; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DEFECTIVE VIRUSES; FEMALE; FOLLOW-UP STUDIES; GENES, NEF; HIV INFECTIONS; HIV-1; HUMANS; LONGITUDINAL STUDIES; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, VIRAL;

EID: 0033589778     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299309801     Document Type: Article

References (52)

1. Learmont J, Tindall B, Evans L, Cunningham A, Cunningham P, Wells J, Penny R, Kaldor J, and Cooper DA: Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet 1992;340:863-867.
2. Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker DJ, McPhee DA, Greenway AL, Ellet A, Chatfield C, Lawson VA, Crowe S, Maerz A, Sonza S, Learmont J, Sullivan JS, Cunningham A, Dwyer D, Dowton D, and Mills J: Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 1995;270:988-991.
3. Learmont JC, Gezcy AF, Mills J, Ashton LJ, Raynes-Greenow CH, Garsia RJ, Dyer W, McIntyre L, Oelrichs RB, Rhodes DI, Deacon NJ, and Sullivan J: Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. N Engl J Med 1999;340:1715-1722.
4. Cohen J: Novel campaign to test live HIV vaccine. Science 1997; 277:1035.
5. Daniel MD, Kirchhoff F, Czajak SC, Sehgal PK, and Desrosiers RC: Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 1992;258:1938-1941.
6. Dyer WB, Ogg GS, Demoitie M-A, Jin X, Geczy AF, Rowland-Jones SL, McMichael AJ, Nixon DF, and Sullivan JS: Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1. J Virol 1999;73:436-443.
7. Baba T, Liska V, Khimani AH, Ray NB, Dailey PJ, Penninck D, Bronson R, Greene MF, McClure HM, Martin LN, and Ruprecht RM: Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques. Nature Med 1999;5:194-203.
8. Dyer WB, Geczy AF, Kent SJ, McIntyre LB, Blasdall SA, Learmont J, and Sullivan JS: Lymphoproliferative immune function in the Sydney Blood Bank Cohort, infected with natural nef/long terminal repeat mutants, and in other long-term survivors of transfusion-acquired HIV-1 infection. AIDS 1997;11:1565-1574.
9. Roederer M, Dubs JG, Anderson MT, Raju PA, Herzenberg LA, and Herzenberg LA: CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest 1995;95:2061-2066.
10. Ullum H, Cozzi Lepri A, Victor J, Skinhoj P, Phillips AN, and Klarlund Pedersen B: Increased losses of CD4+CD45RA+ cells in late stages of HIV infection is related to increased risk of death: Evidence from a cohort of 347 HIV-infected individuals. AIDS 1997;11:1479-1485.
11. Zaunders J, Carr A, McNally L, Penny R, and Cooper D: Effects of primary HIV-1 infection on subsets of CD4+ and CD8+ T lymphocytes. AIDS 1995;9:561-566.
12. Kelleher AD, Carr A, Zaunders J, and Cooper DA: Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J Infect Dis 1996;173:321-329.
13. Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debré P, and Leibowitch J: Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997;277:112-116.
14. Connors M, Kovacs JA, Krevat S, Gea-Banacloche JC, Sneller MC, Flanigan M, Metcalf JA, Walker RE, Falloon J, Baseler M, Stevens R, Feuerstein I, Masur H, and Lane HC: HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nature Med 1997;3:533-540.
15. Broström C, Sönnerborg A, Lindback S, and Gaines H: Low relative frequencies of CD26+ CD4+ cells in long-term nonprogressing human immunodeficiency virus type 1-infected subjects. Clin Diag Lab Immunol 1998;5:662-666.
16. Klein MR, van Baalen CA, Holwerda AM, Kerkhof Garde SR, Bende RJ, Keet IPM, Eeftinck-Schattenkerk J-KM, Osterhaus ADME, Schuitemaker H, and Miedema F: Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics. J Exp Med 1995;181:1365-1372.
17. Goulder PJR, Phillips RE, Colbert RA, McAdam S, Ogg G, Nowak MA, Giangrande P, Luzzi G, Morgan B, Edwards A, McMichael AJ, and Rowland-Jones S: Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nature Med 1997;3:212-217.
18. Ho H-N, Hutlin LE, Mitsuyasu RT, Matud JL, Hausner MA, Bockstoce D, Chou C-C, O'Rourke S, Taylor JMG, and Giorgi JV: Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens. J Immunol 1993;150:3070-3079.
19. Fiorentino S, Dalod M, Olive D, Guillet J-G, and Gomard E: Predominant involvement of CD8+CD28-lymphocytes in human immunodeficiency virus-specific cytotoxic activity. J Virol 1996; 70:2022-2026.
20. Dalod M, Fiorentino S, Delamare C, Rouzioux C, Sicard D, Guillet J-G, and Gomard E: Delayed virus-specific CD8+ cytotoxic T lymphocyte activity in an HIV-infected individual with high CD4+ cells counts: Correlation with various parameters of disease progression. AIDS Res Hum Retroviruses 1996;12:497-506.
21. Giorgi JV, Ho N-H, Hirji K, Chou C-C, Hultin LE, O'Rourke S, Park L, Margolick JB, Ferbas J, Phair JP, and the Multicentre AIDS Cohort Study Group: CD8+ lymphocyte activation at human immunodeficency virus type 1 seroconversion: Development of HLA-DR+CD38-CD8+ cells is associated with subsequent stable CD4+ cell levels. J Infect Dis 1994;170:775-781.
22. Bofill M, Mocroft A, Lipman M, Medina E, Borthwick NJ, Sabin CA, Timms A, Winter M, Baptista L, Johnson MA, Lee CA, Phillips AN, and Janossy G: Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1 infected patients. AIDS 1996;10:827-834.
23. Mocroft A, Bofill M, Lipman M, Medina E, Borthwick N, Timms A, Batista L, Winter M, Sabin CA, Johnson M, Lee CA, Phillips A, and Janossy G: CD8+, CD38+ lymphocyte percent: A useful immunological marker for monitoring HIV-1-infected patients. J Acquir Immune Defic Syndr 1997;14:158-162.
24. Liu Z, Cumberland WG, Hultin LE, Kaplan AH, Detels R, and Giorgi JV: CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:332-340.
25. Ferbas J, Kaplan AH, Hausner MA, Hultin LE, Matud JL, Liu Z, Panicali DL, Nerng-Ho H, Detels R, and Giorgi JV: Virus burden in long-term survivors of human immunodeficiency virus (HIV) infection is a determinant of anti-HIV CD8+ lymphocyte activity. J Infect Dis 1995;172:329-339.
26. Zanussi S, Simonelli C, D'Andrea M, Caffau C, Clerici M, Tirelli U, and De Paoli P: CD8+ lymphocyte phenotype and cytokine production in long-term non-progressor and in progressor patients with HIV-1 infection. Clin Exp Immunol 1996;105:220-224.
27. Barker E, Mackewicz CE, Reyes-Teran G, Sato A, Stranford SA, Fujimura SH, Christopherson C, Chang S-Y, and Levy JA: Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome. Blood 1998;92:3105-3114.
28. Stulnig T, Maczek C, Bock G, Majdic O, and Wick G: Reference intervals for human peripheral blood lymphocyte subpopulations from "healthy" young and aged subjects. Int Arch Allergy Immunol 1995;108:205-210.
29. Neel BG: Role of phosphatases in lymphocyte activation. Curr Opin Immunol 1997;9:405-420.
30. Akbar AN, Terry L, Timms A, Beverley PCL, and Janossy G: Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. J Immunol 1998;140:2171-2178.
31. Bell EB and Sparshott SM: Interconversion of CD45R subsets of CD4 T cells in vivo. Nature (London) 1990;348:163-166.
32. Sprent J: Immunological memory. Curr Opin Immunol 1997;9: 371-379.
33. Sanders ME, Makgoba MW, Sharrow SO, Stephany D, Springer TA, Young HA, and Shaw S: Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2 and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-gamma production. J Immunol 1988;140:1401-1407.
34. Merkenschlager M, Terry L, Edwards R, and Beverley PCL: Limiting dilution analysis of proliferative responses in human lymphocyte populations defined by the monoclonal antibody UCHL1: Implications for differential CD45 expression in T cell memory formation. Eur J Immunol 1988;18:1653-1661.
35. Gerdes J, Lemke H, Baisch H, Wacker H-H, Schwab U, and Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki67. J Immunol 1984;133:1710-1715.
36. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, Polis MA, Haase AT, Feinberg MB, Sullivan JL, Jamieson BD, Zack JA, Picker LJ, and Koup RA: Changes in thymic function with age and during the treatment of HIV infection. Nature (London) 1998;396:690-695.
37. Hellerstein M, Hanley MB, Cesar D, Siler S, Papageorgopoulos C, Wieder E, Schmidt D, Hoh R, Neese R, Macallan D, Deeks S, and McCune JM: Directly measured kinetics of circulating T lymphocytes in normal and HIV-1 infected humans. Nature Med 1999; 5:83-89.
38. Schnittman SM, Lane HC, Greenhouse J, Justment JS, Baseler M, and Fauci AS: Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: Evidence for a role in the selective T-cell functional defects observed in infected individuals. Proc Natl Acad Sci USA 1990;87:6058-6062.
39. Chun T-W, Chadwick K, Margolick J, and Siliciano RF: Differential susceptibility of naive and memory CD4+ T cells to the cytopathic effects of infection with human immunodeficiency virus type 1 strain LAI. J Virol 1997;71:4436-4444.
40. Roederer M, Raju PA, Mitra DK, Herzenberg LA, and Herzenberg LA: HIV does not replicate in naive CD4 T cells stimulated with CD3/CD28. J Clin Invest 1997;99:1555-1564.
41. Spina CA, Prince HE, and Richman DD: Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro. J Clin Invest 1997;99:1774-1785.
42. Woods TC, Roberts BD, Butera ST, and Folks TM: Loss of inducible virus in CD45RA naive cells after human immunodeficiency virus-1 entry accounts for preferential viral replication in CD45RO memory cells. Blood 1997;89:1635-1641.
43. Jaleco AC, Covas MJ, Pinto LA, and Victorino RMM: Distinct alterations in the distribution of CD45RO+ T-cell subsets in HIV-2 compared with HIV-1 infection. AIDS 1994;8:1663-1668.
44. Giorgi JV, Boumsell L, and Autran B: Reactivity of workshop T-cell section mAb with circulating CD4+ and CD8+ T cells in HIV disease and following in vitro activation. In: Leukocyte Typing V (Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, and Todd RF, eds.), Vol. 1. Oxford University Press, Oxford, 1995, pp. 446-461.
45. Kestler HW, Ringler DJ, Mori K, Panicali DL, Seghal PK, Daniel MD, and Desrosiers RC: Importance of the nef gene for maintenance of high virus loads and for the development of AIDS. Cell 1991;65:651-652.
46. Cardin RD, Brooks JW, Sarawar SR, and Doherty PC: Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells. J Exp Med 1996;184:863-871.
47. Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, Kalams SA, and Walker BD: Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 1997; 278:1447-1450.
48. Bouscarat F, Levacher-Clergeot M, Dazza M-C, Strauss KW, Girard P-M, Ruggeri C, and Sinet M: Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 1996;12:17-24.
49. Zaunders JJ, Cunningham PH, Kelleher AD, Kaufman GR, Jaramillo AB, Wright R, Smith D, Grey P, Vizzard J, Carr A, and Cooper DA: Potent antiretroviral therapy of primary HIV-1 infection: Partial normalization of T lymphocyte subsets and subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia. J Infect Dis 1999;180:320-329.
50. Lynne JE, Schmid I, Matud JL, Hirji K, Buessow S, Shlian DM, and Giorgi JV: Major expansions of select CD8+ subsets in acute Epstein-Barr virus infection: Comparison with chronic human immunodeficiency virus disease. J Infect Dis 1998;177:1083-1087.
51. Bouscarat F, Levacher M, Landman R, Muffat JM, Girard PM, Saimot AG, Brun VF, and Sinet M: Changes in blood CD8+ lymphocyte activation status and plasma HIV RNA levels during antiretroviral therapy. AIDS 1998;12:1267-1273.
52. Greenough TC, Sullivan JL, and Desrosiers RC: Declining CD4 T cell counts in a person infected with nef-deleted HIV-1. N Engl J Med 1999;340:236-237.